Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Riederer

Showing results (51-60 of 244) with videos related to

Pageof 25
Sort By:
Biomedicines|January 8, 2025
Metabolic Dysfunction in Parkinson's Disease: Unraveling the Glucose-Lipid ConnectionJeswinder Sian-Hulsmann, Peter Riederer, Tanja Maria Michel
Pharmacopsychiatry|January 26, 2022
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?Juliane K Mueller, Peter Riederer, Walter E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|February 24, 2021
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentialsWojciech Danysz, Andrzej Dekundy, Astrid Scheschonka, et al.
Parkinsonism & Related Disorders|October 9, 2007
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's diseasePeter Riederer, Manfred Gerlach, Thomas Müller, et al.
Neurotoxicity Research|June 17, 2010
Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?Peter Riederer, Jasmin Bartl, Gerd Laux, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2024
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's diseaseMakoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 14, 2012
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's researchMelita Salkovic-Petrisic, Ana Knezovic, Siegfried Hoyer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 28, 2018
Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymesJean Chen Shih, Peter Riederer, Wakako Maruyama, et al.
CNS & Neurological Disorders Drug Targets|March 25, 2015
Lewy Bodies: A Spectator or Salient Killer?Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, et al.
Attention Deficit and Hyperactivity Disorders|April 4, 2014
A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infectionEleni Koutsilieri, Peter Riederer, Stefan du Plessis, et al.
Pageof 25

Showing results (51-60 of 244) with videos related to

Sort By:
Pageof 25
Biomedicines|January 8, 2025
Metabolic Dysfunction in Parkinson's Disease: Unraveling the Glucose-Lipid ConnectionJeswinder Sian-Hulsmann, Peter Riederer, Tanja Maria Michel
Pharmacopsychiatry|January 26, 2022
Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?Juliane K Mueller, Peter Riederer, Walter E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|February 24, 2021
Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentialsWojciech Danysz, Andrzej Dekundy, Astrid Scheschonka, et al.
Parkinsonism & Related Disorders|October 9, 2007
Relating mode of action to clinical practice: dopaminergic agents in Parkinson's diseasePeter Riederer, Manfred Gerlach, Thomas Müller, et al.
Neurotoxicity Research|June 17, 2010
Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?Peter Riederer, Jasmin Bartl, Gerd Laux, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2024
Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's diseaseMakoto Naoi, Wakako Maruyama, Masayo Shamoto-Nagai, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 14, 2012
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's researchMelita Salkovic-Petrisic, Ana Knezovic, Siegfried Hoyer, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 28, 2018
Introduction to the special issue on monoamine oxidase A and B: eternally enigmatic isoenzymesJean Chen Shih, Peter Riederer, Wakako Maruyama, et al.
CNS & Neurological Disorders Drug Targets|March 25, 2015
Lewy Bodies: A Spectator or Salient Killer?Jeswinder Sian-Hulsmann, Camelia Monoranu, S Strobel, et al.
Attention Deficit and Hyperactivity Disorders|April 4, 2014
A short review on the relation between the dopamine transporter 10/10-repeat allele and ADHD: implications for HIV infectionEleni Koutsilieri, Peter Riederer, Stefan du Plessis, et al.
Pageof 25